Johanna G. H. van Nes

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Esther M. de Kruijf, Johanna G. H. van Nes, Cornelis J.�H. van de Velde et al. · Breast Cancer Research and Treatment · 2010 · 286 citations · Full text

Medicine, Cancer Biology, Oncology +15

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

Esther M. de Kruijf, Anita Sajet, Johanna G. H. van Nes et al. · The Journal of Immunology · 2010 · 263 citations · Full text

Life Sciences, Immunology, Oncology +16

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

Johanna G. H. van Nes, Hein Putter, Jean‐Pierre Julien et al. · Breast Cancer Research and Treatment · 2008 · 128 citations · Full text

Medicine, Oncology, Breast Oncology +10

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer

Esther M. de Kruijf, Johanna G. H. van Nes, Anita Sajet et al. · Clinical Cancer Research · 2010 · 110 citations · Full text

Life Sciences, Immunology, Oncology +17

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

Anneke Q. van Hoesel, Cornelis J.�H. van de Velde, Peter J.K. Kuppen et al. · Breast Cancer Research and Treatment · 2012 · 85 citations

Medicine, Cancer Biology, Oncology +12